
NASDAQHealthcareMedical - Diagnostics & Research
最新数据
US$511.41
+US$4.7403 · +0.94%
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
常规交易时段
US$511.41
+US$4.7403 · +0.94%
盘中时间采用ET。市场数据可能有所延迟。
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
日内区间
当前US$511.41
52周区间
当前US$511.41
盘中时间采用ET。市场数据可能有所延迟。
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
日内区间
当前US$511.41
52周区间
当前US$511.41
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 43.04亿 USD | 38.98亿 USD | 36.61亿 USD | 33.67亿 USD | 32.15亿 USD |
| 销货成本 | 16.44亿 USD | 15.19亿 USD | 14.71亿 USD | 13.63亿 USD | 13.26亿 USD |
| 毛利 | 26.6亿 USD | 23.79亿 USD | 21.9亿 USD | 20.04亿 USD | 18.89亿 USD |
| 研究与开发 | 2.51亿 USD | 2.2亿 USD | 1.91亿 USD | 2.55亿 USD | 1.61亿 USD |
| 销售、一般及管理费用 | 10.48亿 USD | 10.31亿 USD | 9.02亿 USD | 8.51亿 USD | 7.96亿 USD |
| 营业费用 | 13亿 USD | 12.51亿 USD | 10.93亿 USD | 11.06亿 USD | 9.57亿 USD |
| 利息收入 | 242.3万 USD | 1269.9万 USD | 562.9万 USD | 106.5万 USD | 43.4万 USD |
| 利息支出 | 3826.5万 USD | 3120.5万 USD | 4158.1万 USD | 3985.8万 USD | 2980.8万 USD |
| 折旧和摊销 | 1.45亿 USD | 1.3亿 USD | 1.15亿 USD | 1.12亿 USD | 1.05亿 USD |
| 营业利润 | 13.6亿 USD | 11.28亿 USD | 10.97亿 USD | 8.99亿 USD | 9.32亿 USD |
| 净利润 | 10.59亿 USD | 8.88亿 USD | 8.45亿 USD | 6.79亿 USD | 7.45亿 USD |
公司数据更新于 2026年10月8日。
第三方分析师预期可能变化,并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T784.15亿0.06%129.41万亿 JPY0.09%JP¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI13.95亿0.06%2.3万亿 USD0.03%US$379.9-0.30%
Vanguard S&P 500 ETFVOO11.66亿0.07%1.8万亿 USD0.03%US$712.49-0.26%
Vanguard Morningstar Mid-Cap ETFVO9.5亿0.42%2264亿 USD0.03%US$80.015-0.16%
Invesco QQQ Trust, Series 1QQQ8.41亿0.17%5084.84亿 USD0.18%US$754.56-0.42%
iShares Core S&P 500 ETFIVV5.31亿0.06%8996.25亿 USD0.03%US$778.52-0.26%
Vanguard Morningstar Growth ETFVUG5.2亿0.14%3846亿 USD0.03%US$92.11-0.34%
State Street SPDR S&P 500 ETFSPY4.95亿0.06%8190.39亿 USD0.09%US$775.12-0.27%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
Invesco QQQ Trust, Series 1QQQ
iShares Core S&P 500 ETFIVV
Vanguard Morningstar Growth ETFVUG
State Street SPDR S&P 500 ETFSPYAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。